Abstract Immune checkpoint inhibitors (ICI) improve overall survival in patients with metastatic urothelial cancer (mUC), but therapeutic success at the individual patient level varies significantly. Here we identify predictive markers of response, based on whole-genome DNA (n = 70) and RNA-sequenci...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!